
Syneos Health SYNH
$ 42.98
0.0%
Quarterly report 2023-Q1
added 05-10-2023
Syneos Health P/E Ratio 2011-2025 | SYNH
Annual P/E Ratio Syneos Health
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 39.8 | 40.2 | 49.2 | 217 | -21.3 | 24.7 | 20.8 | -52.9 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 217 | -52.9 | 39.7 |
P/E Ratio of other stocks in the Diagnostics research industry
| Issuer | P/E Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-10.3 | $ 0.33 | -6.23 % | $ 30.6 M | ||
|
Fluidigm Corporation
FLDM
|
-9.08 | $ 3.75 | 1.08 % | $ 308 M | ||
|
Global Cord Blood Corporation
CO
|
0.485 | $ 2.99 | - | $ 399 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-233 | $ 21.99 | - | $ 562 M | ||
|
Genetron Holdings Limited
GTH
|
-3.07 | $ 4.03 | 0.12 % | $ 80.1 M | ||
|
Chembio Diagnostics
CEMI
|
-0.54 | $ 0.46 | 0.22 % | $ 16.8 M | ||
|
Pacific Biosciences of California
PACB
|
-4.61 | $ 1.97 | -5.74 % | $ 500 M | ||
|
Koninklijke Philips N.V.
PHG
|
9.27 | $ 27.3 | -5.5 % | $ 20 B | ||
|
Meridian Bioscience
VIVO
|
31.8 | $ 33.97 | - | $ 1.49 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.138 | $ 0.48 | -20.0 % | $ 1.06 M | ||
|
Quotient Limited
QTNT
|
-1.65 | $ 0.32 | -11.32 % | $ 1.1 M | ||
|
Bioventus
BVS
|
-2.25 | $ 6.94 | 3.43 % | $ 435 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
39.9 | $ 165.21 | - | $ 10.7 B | ||
|
Thermo Fisher Scientific
TMO
|
32.5 | $ 557.63 | -1.09 % | $ 213 B | ||
|
Trinity Biotech plc
TRIB
|
129 | $ 1.0 | -1.96 % | $ 61.9 M | ||
|
Heska Corporation
HSKA
|
-42.4 | $ 119.99 | - | $ 1.31 B | ||
|
Twist Bioscience Corporation
TWST
|
-11.8 | $ 33.57 | -1.78 % | $ 1.95 B | ||
|
Motus GI Holdings
MOTS
|
-0.0769 | $ 0.17 | -34.28 % | $ 263 K | ||
|
Biocept
BIOC
|
-0.185 | $ 0.43 | -13.05 % | $ 7.29 M | ||
|
Invitae Corporation
NVTA
|
-5.12 | $ 0.09 | - | $ 21.2 M | ||
|
DermTech
DMTK
|
-0.421 | $ 0.09 | -11.32 % | $ 2.94 M | ||
|
Akumin
AKU
|
-0.479 | $ 0.29 | -17.87 % | $ 25.9 M | ||
|
Castle Biosciences
CSTL
|
38.9 | $ 24.15 | 0.79 % | $ 671 M | ||
|
DarioHealth Corp.
DRIO
|
-0.73 | $ 15.33 | -2.67 % | $ 435 M | ||
|
Exagen
XGN
|
-1.32 | $ 11.89 | -0.17 % | $ 210 M | ||
|
PerkinElmer
PKI
|
52.3 | $ 115.24 | -0.91 % | $ 14.7 B | ||
|
OpGen
OPGN
|
0.761 | $ 1.96 | -16.95 % | $ 1.54 M | ||
|
DexCom
DXCM
|
90.1 | $ 69.23 | -1.98 % | $ 26.7 B | ||
|
Organovo Holdings
ONVO
|
-1.25 | $ 2.12 | -2.3 % | $ 19.4 M | ||
|
Burning Rock Biotech Limited
BNR
|
-7.25 | $ 12.26 | 4.79 % | $ 130 M | ||
|
Danaher Corporation
DHR
|
39 | $ 216.9 | -1.86 % | $ 159 B | ||
|
Quidel Corporation
QDEL
|
13 | $ 28.19 | -4.38 % | $ 1.19 B | ||
|
Neogen Corporation
NEOG
|
-0.933 | $ 6.16 | -0.81 % | $ 1.34 B | ||
|
Biomerica
BMRA
|
-1.45 | $ 2.93 | -1.15 % | $ 6.73 M | ||
|
Fulgent Genetics
FLGT
|
-10.9 | $ 23.43 | 0.51 % | $ 708 M | ||
|
Psychemedics Corporation
PMD
|
-4.05 | $ 2.67 | -1.84 % | $ 15.3 M | ||
|
Genetic Technologies Limited
GENE
|
-1.29 K | $ 0.77 | - | $ 7.1 B | ||
|
Myriad Genetics
MYGN
|
-7.64 | $ 8.13 | 0.37 % | $ 737 M | ||
|
Renalytix AI plc
RNLX
|
-0.679 | $ 0.21 | 5.66 % | $ 22.7 M | ||
|
Medpace Holdings
MEDP
|
25.2 | $ 580.53 | -2.67 % | $ 18 B | ||
|
IQVIA Holdings
IQV
|
26 | $ 218.13 | 0.32 % | $ 39.5 B | ||
|
CareDx, Inc
CDNA
|
-2.74 | $ 14.67 | 1.1 % | $ 789 M | ||
|
Brainsway Ltd.
BWAY
|
-37.1 | $ 16.59 | -2.5 % | $ 99.4 M | ||
|
Biodesix
BDSX
|
-2.14 | $ 6.55 | -1.5 % | $ 849 M | ||
|
T2 Biosystems
TTOO
|
-0.155 | $ 0.12 | -39.35 % | $ 313 K | ||
|
Guardant Health
GH
|
-13.4 | $ 69.58 | -1.79 % | $ 8.54 B | ||
|
Agilent Technologies
A
|
34.7 | $ 145.85 | -0.5 % | $ 44.3 B | ||
|
Co-Diagnostics
CODX
|
-0.988 | $ 0.57 | -54.76 % | $ 16.7 M | ||
|
Lantheus Holdings
LNTH
|
20.7 | $ 57.33 | -1.38 % | $ 3.97 B |